IRCT20221227056950N1RecruitingPhase 2
The effect of Empagliflozin on left ventricular ejection fraction in non-diabetic patients with acute anterior ST elevation Myocardial infarction treated with primary PCI
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Non-Diabetic patients
- •Patients with ejection fraction=40
- •Patients with anterior ST elevation myocardial infarction
- •Patients undergoing primary percutaneous coronary intervention(PCI)
- •The possibility of patient follow up for electrocardiography
- •Consent to admission to the study
Exclusion Criteria
- •Patients who are candidates for medical therapy after angiography
- •Patients who are candidates for CABG after angiography
- •patients with a history of clinical heart failure
- •patients with a history of Anterior STEMI
- •Patients with a history of PCI on LAD
Investigators
Similar Trials
Not yet recruiting
Unknown
The Impact of Empagliflozin on Left Ventricular Myocardial Stiffness in Heart Failure with Preserved Ejection FractioPatients with heart failure with preserved ejecion fraction (HFpEF)Drug intervention, Empagliflozin, Pressure-Volume LoopHFpEF/I509JPRN-jRCTs071230020Hieda Michinari38
Active, not recruiting
Phase 1
Impact of empagliflozin on left ventricular functionstype 2 diabetesMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-002225-10-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA75
Not yet recruiting
Phase 3
Effect of Empagliflozin on left ventricular volumes in type 2 diabetes or prediabetes patients with heart failure with reduced ejection fractioHeart failure.Heart failure, unspecifiedI50.9IRCT20211219053450N1Ahvaz University of Medical Sciences112
Recruiting
Phase 4
Randomised trial of Empagliflozin and Left ventricular diastolic function in Acute Coronary Syndrome and Type 2 Diabetes (RELACS-T2D)Diabetes mellitusAcute coronary syndromeACTRN12621000355875Fiona Stanley Hospital80
Not yet recruiting
Phase 3
Effect of Empagliflozin on clinical and echocardiographic parameters in patient with reduced LVEF heart failureHeart failureIRCT20210809052117N1Shahid Beheshti University of Medical Sciences44